Literature DB >> 25776950

Autoimmunity: lungs and citrullination.

Lars Klareskog1, Anca I Catrina1.   

Abstract

Anti-citrullinated protein antibodies are a distinctive feature of a subset of patients with rheumatoid arthritis (RA). A new report investigates how lung inflammation in patients with chronic obstructive pulmonary disease affects protein citrullination, providing an additional piece of information on the potential link between airway inflammation and RA.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25776950     DOI： 10.1038/nrrheum.2015.38

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

1.  Citrullination is an inflammation-dependent process.

Authors:  D Makrygiannakis; E af Klint; I E Lundberg; R Löfberg; A-K Ulfgren; L Klareskog; A I Catrina
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

2.  Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.

Authors:  Gudrun Reynisdottir; Reza Karimi; Vijay Joshua; Helga Olsen; Aase Haj Hensvold; Anders Harju; Marianne Engström; Johan Grunewald; Sven Nyren; Anders Eklund; Lars Klareskog; Carl Magnus Sköld; Anca Irinel Catrina
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

3.  Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?

Authors:  M Kristen Demoruelle; Michael H Weisman; Philip L Simonian; David A Lynch; Peter B Sachs; Isabel F Pedraza; Annie R Harrington; Jason R Kolfenbach; Christopher C Striebich; Quyen N Pham; Colin D Strickland; Brian D Petersen; Mark C Parish; Lezlie A Derber; Jill M Norris; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheum       Date:  2011-12-19

4.  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.

Authors:  Ulrike Harre; Dan Georgess; Holger Bang; Aline Bozec; Roland Axmann; Elena Ossipova; Per-Johan Jakobsson; Wolfgang Baum; Falk Nimmerjahn; Eszter Szarka; Gabriella Sarmay; Grit Krumbholz; Elena Neumann; Rene Toes; Hans-Ulrich Scherer; Anca Irinel Catrina; Lars Klareskog; Pierre Jurdic; Georg Schett
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

5.  Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.

Authors:  A Jimmy Ytterberg; Vijay Joshua; Gudrun Reynisdottir; Nataliya K Tarasova; Dorothea Rutishauser; Elena Ossipova; Aase Haj Hensvold; Anders Eklund; C Magnus Sköld; Johan Grunewald; Vivianne Malmström; Per Johan Jakobsson; Johan Rönnelid; Leonid Padyukov; Roman A Zubarev; Lars Klareskog; Anca I Catrina
Journal:  Ann Rheum Dis       Date:  2014-05-09       Impact factor: 19.103

6.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Authors:  Solbritt Rantapää-Dahlqvist; Ben A W de Jong; Ewa Berglin; Göran Hallmans; Göran Wadell; Hans Stenlund; Ulf Sundin; Walther J van Venrooij
Journal:  Arthritis Rheum       Date:  2003-10

7.  Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells.

Authors:  D Makrygiannakis; M Hermansson; A-K Ulfgren; A P Nicholas; A J W Zendman; A Eklund; J Grunewald; C M Skold; L Klareskog; A I Catrina
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

8.  Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis.

Authors:  Elena B Lugli; Raquel E S M Correia; Roman Fischer; Karin Lundberg; Ken R Bracke; Anna B Montgomery; Benedikt M Kessler; Guy G Brusselle; Patrick J Venables
Journal:  Arthritis Res Ther       Date:  2015-01-20       Impact factor: 5.156

9.  Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis.

Authors:  E W Karlson; S-C Chang; J Cui; L B Chibnik; P A Fraser; I De Vivo; K H Costenbader
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

10.  Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition.

Authors:  Khaled Amara; Johanna Steen; Fiona Murray; Henner Morbach; Blanca M Fernandez-Rodriguez; Vijay Joshua; Marianne Engström; Omri Snir; Lena Israelsson; Anca I Catrina; Hedda Wardemann; Davide Corti; Eric Meffre; Lars Klareskog; Vivianne Malmström
Journal:  J Exp Med       Date:  2013-02-25       Impact factor: 14.307
  10 in total
  12 in total

Review 1.  Obstructive lung diseases and risk of rheumatoid arthritis.

Authors:  H Maura Friedlander; Julia A Ford; Alessandra Zaccardelli; Alexsandra V Terrio; Michael H Cho; Jeffrey A Sparks
Journal:  Expert Rev Clin Immunol       Date:  2020-01-06       Impact factor: 4.473

2.  Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: A marginal structural model analysis in the Nurses' Health Study.

Authors:  Jeffrey A Sparks; Tzu-Chieh Lin; Carlos A Camargo; Medha Barbhaiya; Sara K Tedeschi; Karen H Costenbader; Benjamin A Raby; Hyon K Choi; Elizabeth W Karlson
Journal:  Semin Arthritis Rheum       Date:  2017-09-18       Impact factor: 5.532

Review 3.  Causes and consequences of endoplasmic reticulum stress in rheumatic disease.

Authors:  Fatemeh Navid; Robert A Colbert
Journal:  Nat Rev Rheumatol       Date:  2016-12-01       Impact factor: 20.543

4.  Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.

Authors:  Anne-Marie Quirke; Elizabeth Perry; Alison Cartwright; Clive Kelly; Anthony De Soyza; Paul Eggleton; David Hutchinson; Patrick J Venables
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

5.  Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis.

Authors:  Katerina D Samara; Athina Trachalaki; Eliza Tsitoura; Anastasios V Koutsopoulos; Eleni D Lagoudaki; Ismini Lasithiotaki; George Margaritopoulos; Panagiotis Pantelidis; Eleni Bibaki; Nikolaos M Siafakas; Nikolaos Tzanakis; Athol U Wells; Katerina M Antoniou
Journal:  Respir Res       Date:  2017-12-29

Review 6.  Clinical Applications of Synovial Biopsy.

Authors:  Antonio Manzo; Serena Bugatti; Silvia Rossi
Journal:  Front Med (Lausanne)       Date:  2019-05-10

7.  Complex Relationships of Smoking, HLA-DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population-Based Case-Control Study.

Authors:  Anna Karin Hedström; Johan Rönnelid; Lars Klareskog; Lars Alfredsson
Journal:  Arthritis Rheumatol       Date:  2019-07-24       Impact factor: 10.995

8.  Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.

Authors:  Anja Schwenzer; Xia Jiang; Ted R Mikuls; Jeffrey B Payne; Harlan R Sayles; Anne-Marie Quirke; Benedikt M Kessler; Roman Fischer; Patrick J Venables; Karin Lundberg; Kim S Midwood
Journal:  Ann Rheum Dis       Date:  2015-12-09       Impact factor: 19.103

9.  Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.

Authors:  Pieter Meyer; Mahmood Ally; Bridget Hodkinson; Ronald Anderson; Mohammed Tikly
Journal:  Afr Health Sci       Date:  2018-06       Impact factor: 0.927

10.  Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis.

Authors:  Alessandra Zaccardelli; Xinyi Liu; Julia A Ford; Jing Cui; Bing Lu; Su H Chu; Peter H Schur; Cameron B Speyer; Karen H Costenbader; William H Robinson; Jeremy Sokolove; Elizabeth W Karlson; Carlos A Camargo; Jeffrey A Sparks
Journal:  Arthritis Res Ther       Date:  2019-11-21       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.